T1	intervention 71 89	mometasone furoate
T2	condition 120 146	acute radiation dermatitis
T3	eligibility 150 202	patients with head and neck squamous cell carcinomas
T4	control 1145 1159	control groups
T5	No-of-participants 1326 1335	Forty-one
T6	outcome-Measure 1194 1209	severity of ARD
T8	outcome 1698 1718	itch and pain scores
T7	outcome 1486 1499	stages of ARD
